Evidence map›Paper›PMID 28861042›Full record

ReviewFrontiers in endocrinology2017

3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8?

Noushafarin Khajavi, Stefan Mergler, Heike Biebermann

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. TRPM8 Regulates Mitochondrial CaJournal of cellular and molecular medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?International journal of molecular sciences · 2020
    Review
  9. Thyroid Hormone Metabolite 3-Iodothyronamine (T1AM) Alleviates Hypoxia/Reoxygenation-Induced Cardiac Myocyte Apoptosis via Akt/FoxO1 Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  10. Article
  11. Article
  12. Review
  13. Recent Progress in TRPM8 Modulation: An Update.International journal of molecular sciences · 2019
    Review
  14. TRPM8 Channels and Dry Eye.Pharmaceuticals (Basel, Switzerland) · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Noushafarin KhajaviInstitute for Experimental Pediatric Endocrinology, Charité University of Medicine Berlin, Berlin, Germany.
Stefan MerglerDepartment of Ophthalmology, Charité University of Medicine Berlin, Berlin, Germany.
Heike BiebermannInstitute for Experimental Pediatric Endocrinology, Charité University of Medicine Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The decarboxylated and deiodinated thyroid hormone (TH) derivative, 3-iodothyronamine (3-T

Indexed as

3-iodothyronaminecalciuminflammationthermoregulationtransient receptor potential channel

Identifiers

PMID28861042
PMCPMC5561014
OpenAlexW2748327758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.